Preoperative β-Blocker Use in Coronary Artery Bypass Grafting Surgery | Zendy

William T. Brinkman | Zendy; Morley A. Herbert | Zendy; Sean M. O’Brien | Zendy; Giovanni Filardo | Zendy; Syma L. Prince | Zendy; Todd Dewey | Zendy; Mitchell J. Magee | Zendy; William H. Ryan | Zendy; Michael J. Mack | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Preoperative β-Blocker Use in Coronary Artery Bypass Grafting Surgery

Author(s) -

William T. Brinkman,

Morley A. Herbert,

Sean M. O’Brien,

Giovanni Filardo,

Syma L. Prince,

Todd Dewey,

Mitchell J. Magee,

William H. Ryan,

Michael J. Mack

Publication year - 2014

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2014.2356

Subject(s) - medicine , perioperative , propensity score matching , myocardial infarction , stroke (engine) , odds ratio , atrial fibrillation , coronary artery bypass surgery , cardiac surgery , surgery , retrospective cohort study , cardiology , artery , mechanical engineering , engineering

Use of preoperative β-blockers has been associated with a reduction in perioperative mortality for patients undergoing coronary artery bypass grafting (CABG) surgery in observational research studies, which led to the adoption of preoperative β-blocker therapy as a national quality standard.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research